Asbestos Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Bareilly, Uttar Pradesh, India, established in 2020.
2020 Bareilly, Uttar Pradesh, India Active
Last Updated:
Access Report
About Asbestos Drugs Private Limited

Asbestos Drugs Private Limited, a active private limited company, was established on 12 July 2020 in Bareilly, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100UP2020PTC130799. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Saif Samdi (Director), Samareen Uroos (Director), Mohd Zeeshan Raza (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 41/2, Al Arif Tower Jagatpur Road Thana Baradari, Bareilly, Uttar Pradesh, 243001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100UP2020PTC130799

  • Registration Number

    130799

  • Incorporation Date

    12 July 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Asbestos Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Asbestos Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Asbestos Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Saif Samdi Director 12 Jul 2020 Current
Samareen Uroos Director 12 Jul 2020 Current
Mohd Zeeshan Raza Director 12 Jul 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Asbestos Drugs.

Enhance accessibility to Asbestos Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Asbestos Drugs revenue growth over time
Asbestos Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Asbestos Drugs?

Unlock access to Asbestos Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Asbestos Drugs?

Asbestos Drugs has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Asbestos Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asbestos Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Asbestos Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Asbestos Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Asbestos Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.

  • Director Appointment

    Progress on Saif Samdi was appointed as a Director was appointed as a Director on 12 Jul 2020 & has been associated with this company since 5 years 7 months . was documented.

  • Director Appointment

    Samareen Uroos was appointed as a Director was appointed as a Director on 12 Jul 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Mohd Zeeshan Raza was appointed as a Director was appointed as a Director on 12 Jul 2020 & has been associated with this company since 5 years 7 months . was completed.

  • Company Incorporation

    Asbestos Drugs Private Limited was registered on 12 Jul 2020 with Roc Kanpur & aged 5 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Asbestos Drugs Private Limited?

The CIN of Asbestos Drugs Private Limited is U24100UP2020PTC130799.

Where is Asbestos Drugs Private Limited headquartered?

Asbestos Drugs Private Limited is headquartered at 41/2, Al Arif Tower Jagatpur Road Thana Baradari, Bareilly, Uttar Pradesh, 243001.

When was Asbestos Drugs Private Limited incorporated?

Asbestos Drugs Private Limited was incorporated on 12 July 2020.

Who are the current directors of Asbestos Drugs Private Limited?

The current directors of Asbestos Drugs Private Limited are

What is the primary industry of Asbestos Drugs Private Limited?

The primary industry of Asbestos Drugs Private Limited is Chemicals.

Is Asbestos Drugs Private Limited a listed company?

Asbestos Drugs Private Limited is unlisted.

What is the capital structure of Asbestos Drugs Private Limited?

The authorized capital of Asbestos Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available